Cubist Systematic Strategies, LLC Glaukos Corp Transaction History

Cubist Systematic Strategies, LLC

$15.8 Billion
Q3 2024

A detailed history of Cubist Systematic Strategies, LLC transactions in Glaukos Corp stock. As of the latest transaction made, Cubist Systematic Strategies, LLC holds 13,780 shares of GKOS stock, worth $2.16 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

13,780

Holding current value

$2.16 Million

% of portfolio

0.01%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$113.62 - $135.39 $1.57 Million - $1.87 Million	13,780 New	13,780 $1.8 Million
Q1 2024 May 15, 2024	SELL	$76.4 - $96.33 $5.87 Million - $7.4 Million	-76,802 Reduced 40.52%	112,718 $10.6 Million
Q4 2023 Feb 14, 2024	BUY	$59.53 - $85.11 $11.3 Million - $16.1 Million	189,520 New	189,520 $15.1 Million
Q2 2023 Aug 14, 2023	BUY	$45.44 - $71.21 $252,555 - $395,785	5,558 New	5,558 $395,000
Q4 2022 Feb 14, 2023	BUY	$40.82 - $57.75 $839,300 - $1.19 Million	20,561 Added 178.56%	32,076 $1.4 Million
Q3 2022 Nov 14, 2022	SELL	$46.84 - $58.49 $830,566 - $1.04 Million	-17,732 Reduced 60.63%	11,515 $613,000
Q2 2022 Aug 15, 2022	BUY	$34.86 - $63.77 $540,190 - $988,179	15,496 Added 112.69%	29,247 $1.33 Million
Q1 2022 May 16, 2022	SELL	$44.33 - $57.82 $1.51 Million - $1.97 Million	-34,012 Reduced 71.21%	13,751 $795,000
Q4 2021 Feb 14, 2022	SELL	$40.27 - $56.99 $792,110 - $1.12 Million	-19,670 Reduced 29.17%	47,763 $2.12 Million
Q3 2021 Nov 15, 2021	BUY	$47.43 - $84.23 $1.9 Million - $3.38 Million	40,104 Added 146.75%	67,433 $3.25 Million
Q2 2021 Aug 16, 2021	BUY	$73.06 - $97.7 $811,331 - $1.08 Million	11,105 Added 68.45%	27,329 $2.32 Million
Q1 2021 May 17, 2021	SELL	$70.43 - $97.42 $568,722 - $786,666	-8,075 Reduced 33.23%	16,224 $1.36 Million
Q4 2020 Feb 16, 2021	BUY	$48.9 - $75.26 $1.18 Million - $1.81 Million	24,097 Added 11929.21%	24,299 $1.83 Million
Q3 2020 Nov 16, 2020	SELL	$37.23 - $50.97 $2.43 Million - $3.33 Million	-65,326 Reduced 99.69%	202 $10,000
Q2 2020 Aug 14, 2020	BUY	$28.78 - $46.83 $435,470 - $708,584	15,131 Added 30.02%	65,528 $2.52 Million
Q1 2020 May 15, 2020	BUY	$25.53 - $70.14 $947,214 - $2.6 Million	37,102 Added 279.07%	50,397 $1.56 Million
Q4 2019 Feb 14, 2020	SELL	$54.18 - $65.64 $1 Million - $1.21 Million	-18,502 Reduced 58.19%	13,295 $724,000
Q3 2019 Nov 14, 2019	BUY	$58.58 - $83.91 $548,191 - $785,229	9,358 Added 41.7%	31,797 $1.99 Million
Q2 2019 Aug 14, 2019	BUY	$63.59 - $78.71 $1.14 Million - $1.41 Million	17,927 Added 397.32%	22,439 $1.69 Million
Q1 2019 May 15, 2019	BUY	$50.75 - $80.54 $47,096 - $74,741	928 Added 25.89%	4,512 $354,000
Q4 2018 Feb 14, 2019	SELL	$52.18 - $67.93 $80,044 - $104,204	-1,534 Reduced 29.97%	3,584 $201,000
Q3 2018 Nov 14, 2018	BUY	$38.13 - $68.37 $195,149 - $349,917	5,118 New	5,118 $332,000

Others Institutions Holding GKOS

# of Institutions

342

Shares Held

46.8M

Call Options Held

132K

Put Options Held

188K

View Full List

About GLAUKOS Corp

Ticker GKOS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,596,900
Market Cap $7.45B
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...

More about GKOS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Account

Cubist Systematic Strategies, LLC Glaukos Corp Transaction History